VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_22-vv-01599 Package ID: USCOURTS-cofc-1_22-vv-01599 Petitioner: H.A. Filed: 2022-10-26 Decided: 2024-01-08 Vaccine: HPV Vaccination date: 2021-03-15 Condition: Guillain-Barré syndrome (“GBS”) Outcome: compensated Award amount USD: 20000 AI-assisted case summary: On October 26, 2022, Hamdi Qasem Almudhari and Huda Nasser Kassem, as parents of H.A., a minor, filed a petition alleging that H.A. suffered Guillain-Barré syndrome (GBS) as a result of receiving the human papillomavirus (HPV), meningococcal (MCV), and tetanus, diphtheria, and acellular pertussis (Tdap) vaccines on March 15, 2021. The respondent, the Secretary of Health and Human Services, denied that the vaccines caused H.A.'s GBS or any other injury. Despite this denial, the parties reached a stipulation recommending an award of compensation, which the Special Master adopted as the decision of the Court. Petitioners were awarded $20,000.00 as reimbursement for a lien for services rendered on behalf of H.A., payable jointly to Petitioners and the State of Connecticut Department of Administrative Services. An additional amount was awarded to purchase an annuity contract, representing compensation for all damages available under the National Childhood Vaccine Injury Act. The parties agreed to waive their right to seek review, expediting the entry of judgment. The public decision does not describe the onset of symptoms, specific clinical details, medical tests, treatments, or expert witnesses. Ronald Craig Homer represented the Petitioners, and Ryan Pohlman Miller represented the Respondent. Special Master Nora Beth Dorsey issued the decision. Theory of causation field: Petitioners alleged that H.A. suffered Guillain-Barré syndrome (GBS) as a result of receiving the human papillomavirus (HPV), meningococcal (MCV), and tetanus, diphtheria, and acellular pertussis (Tdap) vaccines on March 15, 2021. The respondent denied causation. The parties reached a stipulation for compensation, which was adopted by the Special Master. The award included $20,000.00 for a lien reimbursement and an amount for an annuity contract. The public decision does not specify the theory of causation, any medical experts, or the mechanism of injury. The decision was based on a stipulation between the parties. Special Master Nora Beth Dorsey issued the decision on January 8, 2024. Petitioners' counsel was Ronald Craig Homer, and Respondent's counsel was Ryan Pohlman Miller. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_22-vv-01599-0 Date issued/filed: 2024-01-08 Pages: 10 Docket text: PUBLIC DECISION (Originally filed: 12/13/2023) regarding 35 DECISION Stipulation. Signed by Special Master Nora Beth Dorsey. (kis) Service on parties made. -------------------------------------------------------------------------------- Case 1:22-vv-01599-UNJ Document 39 Filed 01/08/24 Page 1 of 10 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS Filed: December 13, 2023 * * * * * * * * * * * * * * * HAMDI QASEM ALMUDHARI and * HUDA NASSER KASSEM, parents of * H.A., a minor, * UNPUBLISHED * Petitioners, * No. 22-1599V * v. * Special Master Dorsey * SECRETARY OF HEALTH * Decision Based on Stipulation; Human AND HUMAN SERVICES, * Papillomavirus Vaccine (“HPV”); * Meningococcal Vaccine (“MCV”); Tetanus * Diphtheria, and Acellular Pertussis (“Tdap”) Respondent. * Vaccine; Guillain-Barré Syndrome (“GBS”). * * * * * * * * * * * * * * * Ronald Craig Homer, Conway, Homer, P.C., Boston, MA, for Petitioners. Ryan Pohlman Miller, U.S. Department of Justice, Washington, DC, for Respondent. DECISION BASED ON STIPULATION1 On October 26, 2022, Hamdi Qasem Almudhari and Huda Nasser Kassem (“Petitioners”), as parents of H.A., a minor, filed a petition in the National Vaccine Injury Program2 alleging that as a result of H.A. receiving the human papillomavirus (“HPV”), meningococcal (“MCV”), and tetanus, diphtheria, and acellular pertussis (“Tdap”) vaccines on 1 Because this Decision contains a reasoned explanation for the action in this case, the undersigned is required to post it on the United States Court of Federal Claims’ website and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc in accordance with the E- Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the Internet. In accordance with Vaccine Rule 18(b), Petitioners have 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits within this definition, the undersigned will redact such material from public access. 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-10 to -34 (2018) (“Vaccine Act” or “the Act”). All citations in this Decision to individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa. Case 1:22-vv-01599-UNJ Document 39 Filed 01/08/24 Page 2 of 10 March 15, 2021, H.A. suffered Guillain-Barré syndrome (“GBS”). Petition at Preamble (ECF No. 1). On December 14, 2023, the parties filed a stipulation recommending an award of compensation to Petitioners. Stipulation (ECF No. 34). Respondent denies that the HPV, Tdap, and MCV vaccines caused H.A.’s GBS or any other injury, or his current condition. Nevertheless, the parties agree to the joint stipulation, attached hereto as Appendix A. The undersigned finds the stipulation reasonable and adopts it as the decision of the Court in awarding damages, on the terms set forth therein. The parties stipulate that Petitioners shall receive the following compensation: a. A lump sum of $20,000.00, representing reimbursement of a lien for services rendered on behalf of H.A., in the form of a check payable jointly to Petitioners and the State of Connecticut Department of Administrative Services, and mailed to Connecticut Department of Administrative Services Collection Services 450 Columbus Boulevard, Suite 1001 Hartford, CT 06103 Case Number: 3266155 Petitioners agree to endorse this check to the State of Connecticut Department of Administrative Services. b. An amount sufficient to purchase the annuity contract described in paragraph 10 of the stipulation, paid to the life insurance company from which the annuity will be purchased (the “Life Insurance Company”). Stipulation at ¶ 8. This amount represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a). The undersigned approves the requested amount for Petitioners’ compensation. Accordingly, an award should be made consistent with the stipulation. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.3 IT IS SO ORDERED. s/Nora B. Dorsey Nora B. Dorsey 3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of notice renouncing the right to seek review. 2 Case 1:22-vv-01599-UNJ Document 39 Filed 01/08/24 Page 3 of 10 Special Master 3 Case 1:22-vv-01599-UNJ Document 39 Filed 01/08/24 Page 4 of 10 Case 1:22-vv-01599-UNJ Document 39 Filed 01/08/24 Page 5 of 10 Case 1:22-vv-01599-UNJ Document 39 Filed 01/08/24 Page 6 of 10 Case 1:22-vv-01599-UNJ Document 39 Filed 01/08/24 Page 7 of 10 Case 1:22-vv-01599-UNJ Document 39 Filed 01/08/24 Page 8 of 10 Case 1:22-vv-01599-UNJ Document 39 Filed 01/08/24 Page 9 of 10 Case 1:22-vv-01599-UNJ Document 39 Filed 01/08/24 Page 10 of 10 ================================================================================ DOCUMENT 2: USCOURTS-cofc-1_22-vv-01599-cl-extra-10736539 Date issued/filed: 2024-01-08 Pages: 1 Docket text: Supplementary opinion from CourtListener cluster 10269949 -------------------------------------------------------------------------------- In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS Filed: December 13, 2023 * * * * * * * * * * * * * * * HAMDI QASEM ALMUDHARI and * HUDA NASSER KASSEM, parents of * H.A., a minor, * UNPUBLISHED * Petitioners, * No. 22-1599V * v. * Special Master Dorsey * SECRETARY OF HEALTH * Decision Based on Stipulation; Human AND HUMAN SERVICES, * Papillomavirus Vaccine (“HPV”); * Meningococcal Vaccine (“MCV”); Tetanus * Diphtheria, and Acellular Pertussis (“Tdap”) Respondent. * Vaccine; Guillain-Barré Syndrome (“GBS”). * * * * * * * * * * * * * * * Ronald Craig Homer, Conway, Homer, P.C., Boston, MA, for Petitioners. Ryan Pohlman Miller, U.S. Department of Justice, Washington, DC, for Respondent. DECISION BASED ON STIPULATION1 On October 26, 2022, Hamdi Qasem Almudhari and Huda Nasser Kassem (“Petitioners”), as parents of H.A., a minor, filed a petition in the National Vaccine Injury Program2 alleging that as a result of H.A. receiving the human papillomavirus (“HPV”), meningococcal (“MCV”), and tetanus, diphtheria, and acellular pertussis (“Tdap”) vaccines on 1 Because this Decision contains a reasoned explanation for the action in this case, the undersigned is required to post it on the United States Court of Federal Claims’ website and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc in accordance with the E- Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the Internet. In accordance with Vaccine Rule 18(b), Petitioners have 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits within this definition, the undersigned will redact such material from public access. 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-10 to -34 (2018) (“Vaccine Act” or “the Act”). All citations in this Decision to individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa. March 15, 2021, H.A. suffered Guillain-Barré syndrome (“GBS”). Petition at Preamble (ECF No. 1). On December 14, 2023, the parties filed a stipulation recommending an award of compensation to Petitioners. Stipulation (ECF No. 34). Respondent denies that the HPV, Tdap, and MCV vaccines caused H.A.’s GBS or any other injury, or his current condition. Nevertheless, the parties agree to the joint stipulation, attached hereto as Appendix A. The undersigned finds the stipulation reasonable and adopts it as the decision of the Court in awarding damages, on the terms set forth therein. The parties stipulate that Petitioners shall receive the following compensation: a. A lump sum of $20,000.00, representing reimbursement of a lien for services rendered on behalf of H.A., in the form of a check payable jointly to Petitioners and the State of Connecticut Department of Administrative Services, and mailed to Connecticut Department of Administrative Services Collection Services 450 Columbus Boulevard, Suite 1001 Hartford, CT 06103 Case Number: 3266155 Petitioners agree to endorse this check to the State of Connecticut Department of Administrative Services. b. An amount sufficient to purchase the annuity contract described in paragraph 10 of the stipulation, paid to the life insurance company from which the annuity will be purchased (the “Life Insurance Company”). Stipulation at ¶ 8. This amount represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a). The undersigned approves the requested amount for Petitioners’ compensation. Accordingly, an award should be made consistent with the stipulation. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.3 IT IS SO ORDERED. s/Nora B. Dorsey Nora B. Dorsey 3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of notice renouncing the right to seek review. 2 Special Master 3 ================================================================================ DOCUMENT 3: USCOURTS-cofc-1_22-vv-01599-cl-extra-10734216 Date issued/filed: 2024-09-19 Pages: 1 Docket text: Supplementary opinion from CourtListener cluster 10267626 -------------------------------------------------------------------------------- In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS Filed: August 6, 2024 * * * * * * * * * * * * * HAMDI QASEM ALMUDHARI and * HUDA NASSER KASSEM, parents of * H.A., a minor, * UNPUBLISHED * Petitioners, * No. 22-1599V * v. * Special Master Dorsey * SECRETARY OF HEALTH * Attorneys’ Fees and Costs. AND HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * * Ronald Craig Homer, Conway, Homer, P.C., Boston, MA, for Petitioners. Ryan Pohlman Miller, U.S. Department of Justice, Washington, DC, for Respondent. DECISION AWARDING ATTORNEYS’ FEES AND COSTS1 On October 26, 2022, Hamdi Qasem Almudhari and Huda Nasser Kassem (“Petitioners”), as parents of H.A., a minor, filed a petition in the National Vaccine Injury Program2 alleging that as a result of H.A. receiving the human papillomavirus (“HPV”), meningococcal (“MCV”), and tetanus, diphtheria, and acellular pertussis (“Tdap”) vaccines on March 15, 2021, H.A. suffered Guillain-Barré syndrome (“GBS”). Petition at Preamble (ECF 1 Because this unpublished Decision contains a reasoned explanation for the action in this case, the undersigned is required to post it on the United States Court of Federal Claims’ website and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the Internet. In accordance with Vaccine Rule 18(b), Petitioners have 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits within this definition, the undersigned will redact such material from public access. 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-10 to -34 (2018) (“Vaccine Act” or “the Act”). All citations in this Decision to individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa. 1 No. 1). On December 13, 2023, the undersigned issued a Decision Based on Stipulation,. Decision Based on Stipulation dated Dec. 13, 2023 (ECF No. 35). On May 31, 2024, Petitioners filed an application for attorneys’ fees and costs. Petitioners’ Application for Attorneys’ Fees and Costs (“Pet. Mot.”), filed May 31, 2024 (ECF No. 40). Petitioners request compensation in the amount of $30,560.18, representing $30,025.00 in attorneys’ fees and $535.18 in attorneys’ costs. Id. at 1-2. Petitioners have not incurred any costs. Id. at 2. Respondent filed a response on June 1, 2024, stating he “is satisfied the statutory requirements for an award of attorneys’ fees and costs are met in this case.” Respondent’s Response to Pet. Mot., filed June 1, 2024 (ECF No. 42). Petitioners did not file a reply. The matter is now ripe for disposition. Petitioners request the following hourly rates for the work of their counsel: for Ms. Christina Ciampolilo, $425.00 per hour for work performed in 2022 and $470.00 per hour for work performed in 2023; for Ms. Meredith Daniels, $410.00 per hour for work performed in 2022, $455.00 per hour for work performed in 2023, and $485.00 per hour for work performed in 2024; for Mr. Ronald Homer, $475.00 per hour for work performed in 2022, $500.00 per hour for work performed in 2023, and $525.00 per hour for work performed in 2024; for Mr. Patrick Kelly, $305.00 per hour for work performed in 2023 and $345.00 per hour for work performed in 2024; for Mr. Nathaniel Enos, $320.00 per hour for work performed in 2023; and for Mr. Joseph Pepper, $415.00 per hour for work performed in 2022 and $455.00 per hour for work performed in 2023. Petitioner also requests rates between $155.00 and $195.00 for work of their counsel’s paralegals performed from 2021 to 2024. The undersigned finds the rates are generally consistent with what counsel have previously been awarded for their Vaccine Program work and reasonable herein. Additionally, the undersigned finds the 2024 rates for Ms. Daniels and Mr. Kelly are consistent with the OSM Attorneys’ Forum Hourly Rate Fee Schedule for 2024 and are reasonable, and will thus award these 2024 rates. The undersigned has reviewed the submitted billing entries and finds the total number of hours billed to be reasonable and will award them in full. Lastly, the undersigned has reviewed the requested costs and finds them to be reasonable and supported with appropriate documentation. Accordingly, the full amount of costs shall be awarded. Therefore, the undersigned finds no cause to reduce the requested hours or rates, or the requested costs. The Vaccine Act permits an award of reasonable attorneys’ fees and costs. § 15(e). Based on the reasonableness of Petitioners’ request, the undersigned GRANTS Petitioners’ motion for attorneys’ fees and costs. Accordingly, the undersigned awards: (1) A lump sum in the amount of $30,560.18, representing reimbursement for reasonable attorneys’ fees and costs, in the form of a check payable jointly to Petitioners and Petitioners’ counsel of record, Mr. Ronald Homer. 2 In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of Court SHALL ENTER JUDGMENT in accordance with this Decision.3 IT IS SO ORDERED. /s/ Nora Beth Dorsey Nora Beth Dorsey Special Master 3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of notice renouncing the right to seek review. 3